Dr. Claudia Hooten, M.D.
What this data tells you about Dr. Hooten
Dr. Claudia Hooten is a retina specialist (ophthalmology) physician in El Paso, TX, with 14 years in practice. Based on federal Medicare data, Dr. Hooten performed 21,304 Medicare services across 4,423 unique beneficiaries.
Between the years covered by Open Payments, Dr. Hooten received a total of $13,878 from 18 pharmaceutical and/or device companies across 78 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in retina specialist (ophthalmology) physician. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Hooten is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Eye injection (Vabysmo/faricimab) | 7,740 | $29 | $125 |
| Retinal imaging (OCT scan) | 2,705 | $34 | $450 |
| Comprehensive eye exam, established patient | 2,692 | $100 | $366 |
| Aflibercept eye injection (Eylea) | 2,028 | $687 | $2,500 |
| Extended exam of the back part of the eye with optic nerve drawing | 1,937 | $13 | $115 |
| Eye injection for retinal disease | 1,411 | $104 | $613 |
| Injection, ranibizumab, 0.1 mg | 1,245 | $185 | $1,000 |
| Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 374 | $215 | $987 |
| Extended exam of the back part of the eye with retinal drawing | 372 | $20 | $125 |
| New patient office visit (45-59 min) | 236 | $127 | $470 |
| Injection, dexamethasone, intravitreal implant, 0.1 mg | 133 | $144 | $429 |
| Compounded drug, not otherwise classified | 103 | $80 | $796 |
| Exam of retinal blood vessels using a special camera after injection of a dye | 87 | $114 | $373 |
| 2d ultrasound scan of eye tissue and structures | 50 | $40 | $263 |
| Destruction of leaking blood vessels of retina using laser | 45 | $256 | $2,844 |
| Comprehensive eye exam, new patient | 37 | $108 | $431 |
| Eye exam, established patient, focused | 29 | $79 | $259 |
| Removal of eye fluid (vitreous) between lens and retina | 21 | $721 | $2,513 |
| Photocoagulation treatment to prevent detachment of retina | 20 | $204 | $1,224 |
| Unclassified drugs | 16 | $2,211 | $6,938 |
| Repair of detached retina with drainage and removal of eye fluid between lens and retina | 12 | $1,001 | $3,782 |
| Removal of membrane of retina | 11 | $845 | $3,189 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (85%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Hooten is a mixed practice specialist, with above-average Medicare volume (top 14% in TX), and consulting-driven industry engagement.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Hooten experienced with eye injection (vabysmo/faricimab)?
Does Dr. Hooten receive payments from pharmaceutical companies?
How do Dr. Hooten's costs compare to other retina specialist (ophthalmology) physicians in El Paso?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology